Ignite Creation Date:
2024-05-06 @ 1:37 PM
Last Modification Date:
2024-10-26 @ 1:17 PM
Study NCT ID:
NCT04070768
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-12-13
First Post:
2019-08-26
Brief Title:
Study of the Safety and Efficacy of Gemtuzumab Ozogamicin GO and Venetoclax in Patients With Relapsed or Refractory CD33 Acute Myeloid LeukemiaBig Ten Cancer Research Consortium BTCRC-AML17-113
Sponsor:
John Quigley
Organization:
Big Ten Cancer Research Consortium
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-09-06
Start Date Type:
ACTUAL
Primary Completion Date:
2023-10-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-10
Completion Date Type:
ESTIMATED
First Submit Date:
2019-08-26
First Submit QC Date:
August 26 2019
Study First Post Date:
2019-08-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-12-12
Last Update Post Date:
2023-12-13
Last Update Post Date Type:
ACTUAL